Artivion Inc. is a global company that develops, produces, and supplies medical devices and implantable human tissues. Its product range includes BioGlue, a polymer derived from bovine blood protein combined with a cross-linking agent, utilized in cardiac, vascular, neurological, and pulmonary surgical applications. The company also offers heart preservation services and the PhotoFix bovine pericardial patch, in addition to E-vita Open Plus and E-vita Open Neo devices. For the treatment of aortic vascular conditions, Artivion provides specialized stent graft systems. These include E-xtra…
| Price | $23.87 |
|---|---|
| Market cap | $1.16B |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Exchange | NYSE |
| 52-week range | 19.16-48.25 |
| Beta | 1.25 |
Explore AORT's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.